Pricing Log in Create free account

MARKER THERAPEUTICS, INC. (MRKR) vs Neuphoria Therapeutics Inc. (NEUP)

MARKER THERAPEUTICS, INC. and Neuphoria Therapeutics Inc. are both Biotechnology companies. MARKER THERAPEUTICS, INC. and Neuphoria Therapeutics Inc. are of similar size ($15.0M and $14.9M). Neuphoria Therapeutics Inc. grew revenue faster over the last twelve months: 3,535.1% against −46.2%. Across the 15 metrics below, Neuphoria Therapeutics Inc. leads on 11 and MARKER THERAPEUTICS, INC. on 4.

Valuation

Metric MRKR NEUP Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 0.79 9.40
P/B 1.46 0.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.39 0.66
EV/Sales 1.88 (0.42) 9.02
Earnings yield (49.75%) (180.00%) (32.88%)
Free cash flow yield (123.23%) (99.13%) (23.13%)

Profitability

Metric MRKR NEUP Biotechnology median
Gross margin 134.12% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.87%) (61.70%) (51.96%)
Return on assets (59.33%) (46.95%) (46.06%)
Return on invested capital (566.75%) (232.67%) 0.00%

Growth

Metric MRKR NEUP Biotechnology median
Revenue growth (TTM) (46.19%) 3,535.05% 6.76%
EPS growth (last fiscal year) 33.61% (1,230.43%) 29.88%
Revenue growth, 5-year CAGR 50.02% 19.07% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRKR NEUP Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 6.03 27.85 4.97
Net debt to EBITDA 1.32 1.26 1.01

Dividend

Metric MRKR NEUP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MRKR NEUP Biotechnology median
Market cap 14.93m 14.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack